Trial Profile
A Randomized, Double-Blind, Placebo- and Active-Comparator-Controlled, Parallel-Group Study of Rofecoxib and Diclofenac Sodium in the Treatment of Post-Bunionectomy Surgery Pain
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 May 2022
Price :
$35
*
At a glance
- Drugs Rofecoxib (Primary) ; Diclofenac
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme Corp.
- 26 Jan 2010 Planned patient number (240) added and trial phase changed from II/III to III as reported by ClinicalTrials.gov.
- 26 Jan 2010 Actual end date (Dec 2003) added as reported by ClinicalTrials.gov.
- 25 Oct 2005 New trial record.